Krohn et al., 1952 - Google Patents
"-'Allergic Rhinitis: Tocopherol TherapyKrohn et al., 1952
View PDF- Document ID
- 11149184749928436496
- Author
- Krohn B
- Pottenger Jr F
- Publication year
- Publication venue
- Annals of Western Medicine and Surgery
External Links
Snippet
SIX cases of allergic rhinitis in which dl-alphatocopherol relieved the edema and exudation are presented. The edema and exudation returned when tocopherol was withdrawn; they disappeared again when the patients resumed taking tocopherol. Dl-alpha-tocopherol …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/857—Dermatitis
- Y10S514/861—Eczema
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/826—Asthma
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ranich et al. | Protective effects of dietary phytoestrogens in chronic renal disease | |
| Stevenson et al. | Determinants of bone density in normal women: risk factors for future osteoporosis? | |
| RU2199317C2 (en) | Method for decreasing sickness rate of necrotizing enterocolitis in children (versions) | |
| Tannenbaum et al. | The genesis and growth of tumors: IV. Effects of varying the proportion of protein (casein) in the diet | |
| Horrobin et al. | The nutritional regulation of T lymphocyte function | |
| György et al. | Further observations on the production and prevention of dietary hepatic injury in rats | |
| Fisher et al. | Cholesterol-lowering effects of certain grains and of oat fractions in the chick. | |
| US6485752B1 (en) | Composition and method for alleviating joint pain and stiffness | |
| JPH07501457A (en) | Nutritional products for patients with lung disease | |
| COOPER et al. | Metabolic consequences of spinal cord injury | |
| Yacowitz et al. | Effects of dietary calcium upon lipid metabolism in rats fed saturated or unsaturated fat | |
| JPH08500332A (en) | Use of an emulsion for preparing a parenterally administered drug for the treatment of inflammatory diseases | |
| Hove et al. | Covitamin Studies: V. The Interrelation of Alpha-Tocopherol and Essential Unsaturated Fat Acids: Three Figures | |
| Goodman et al. | Idiopathic lipemia with secondary xanthomatosis, hepatosplenomegaly, and lipemic retinalis | |
| CN108245572B (en) | Application of citrus fruit volatile oil and medicine containing citrus fruit volatile oil | |
| Strauss | THE THERAPEUTIC USE OF VITAMIN B, IN POLYNEURITIS AND CARDIOVASCULAR CONDITIONS: CLINICAL INDICATIONS | |
| McCollum et al. | The" vitamine" hypothesis and deficiency diseases: a study of experimental scurvy | |
| Pappenheimer | Muscular disorders associated with deficiency of vitamin E | |
| Krohn et al. | "-'Allergic Rhinitis: Tocopherol Therapy | |
| Cowgill | Vitamin B1 in Relation to the Clinic | |
| Alfin-Slater et al. | The effect of plant sterols on cholesterol levels in the rat | |
| Zilva et al. | The Relation of the Fat-soluble Factor to Rickets and Growth in Pigs. III: With a Report on the Pathological Histology of the Bones, by V. Korenchevsky. From the Dept. of Experimental Pathology, Lister Institute | |
| Waibel et al. | Effect of diet on the development of beta-aminopropionitrile-induced vascular hemorrhage in turkeys | |
| Chase et al. | Linoleic acid absorption in children with cystic fibrosis | |
| Hove et al. | Interrelation between α-Tocopherol and Protein Metabolism: IV. The Cure and Prevention of Stomach Ulcers in Rats: Three Figures |